Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Growth hormone receptor antagonist acromegaly

Somavert [25, 26] PEGylated growth hormone receptor antagonist Acromegaly 2003... [Pg.34]

Pegvisomant is a growth hormone receptor antagonist registered for the treatment of patients with acromegaly who had insufficient benefit from surgery or radiation. [Pg.389]

Trainer PJ, Drake WM, Katznelson L, et al. Treatment of acromegaly with the growth hormone-receptor antagonist Pegvisomant. N Engl J Med 2000 342 1171-1177. [Pg.1422]

Van Der Lely AJ, Hutson R, Trainer PJ, et al. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 2001 358 1754-1759. [Pg.1422]

Kopchick, J.J., Parkinson, C., Stevens, E.C., Trainer, P.J. Growth hormone receptor antagonists discovery, development, and use in patients with acromegaly, Endocr. Rev. 23, 623-646, 2002. [Pg.1417]

See other pages where Growth hormone receptor antagonist acromegaly is mentioned: [Pg.708]    [Pg.519]    [Pg.520]    [Pg.520]    [Pg.1422]    [Pg.1404]    [Pg.74]    [Pg.48]    [Pg.855]    [Pg.149]    [Pg.82]   
See also in sourсe #XX -- [ Pg.708 , Pg.708 ]



SEARCH



Acromegaly

Growth hormone antagonists

Growth hormone receptor

Growth hormone receptor antagonist

Growth hormones

Growth receptor

Hormone antagonists

Hormone receptors

Receptors hormone receptor antagonists

© 2024 chempedia.info